In the fiscal year 2023, Sun Pharmaceutical Industries generated a profit of of approximately 85 billion Indian rupees after taxes. This was a significant increase compared to the previous year. Sun Pharmaceutical Industries is a Indian pharmaceutical company that sells and manufactures formulations and ingredients primarily across India and the United States.
Profit after taxes of Sun Pharmaceutical Industries Limited from financial year 2014 to 2023 (in billion Indian rupees)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Sun Pharma's income FY 2010-2023
- Premium Statistic Dr. Reddy's Laboratories' PAT FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' net worth FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' return on capital employed FY 2013-2023
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2017-2023, by product segment
- Premium Statistic Leading pharmaceutical and drug companies India 2023, by market capitalization
- Basic Statistic Patients reached by Novartis AG's products 2009-2023
- Premium Statistic Cipla's gross revenue FY 2015-2023
- Premium Statistic Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Premium Statistic Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
About the region
10
- Premium Statistic Aurobindo Pharma's net debt to equity ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA FY 2013-2023
- Premium Statistic Aurobindo Pharma's net profit FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA margin FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from ARV formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue share 2023, by market
- Premium Statistic Aurobindo Pharma's revenue from growth market formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's expenditure on R&D FY 2017-2022, by type
- Premium Statistic Aurobindo Pharma's revenue FY 2013-2023
- Premium Statistic Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2023
Selected statistics
10
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic GSK's operating profit by division 2006-2021
Other regions
10
- Basic Statistic Lisinopril out-of-pocket cost U.S. 2004-2021
- Basic Statistic Share of retail Rx by payer oral solid opioids vs. all drugs Canada 2017
- Basic Statistic Canadian vs US price difference of select oral solid opioids 2017
- Premium Statistic Dr. Reddy's Laboratories' revenue from global generics 2022 by region
- Basic Statistic Value of pharmaceutical sales in Luxembourg 2003-2022
- Basic Statistic Value of pharmaceutical sales in Latvia 2003-2022
- Basic Statistic Share value of the generic pharmaceuticals market in Switzerland 2002-2022
- Basic Statistic Share value of the generic pharmaceuticals market in Estonia 2008-2022
- Basic Statistic Share value of the generic pharmaceuticals market in Finland 2012-2021
- Basic Statistic Value of pharmaceutical sales in Ireland 2010-2021
Related statistics
10
- Premium Statistic Net profit of major pharma companies India 2024
- Premium Statistic Dr. Reddy's Laboratories' monthly share trade value at NSE FY 2023
- Premium Statistic Dr. Reddy's Laboratories' revenue FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' EBITDA FY 2014-2023
- Premium Statistic R&D investments as part of sales by leading Indian pharma companies in FY 2012-2021
- Premium Statistic Aurobindo Pharma's ANDA filings FY 2019, by therapy
- Premium Statistic Number of Indian ANDA approvals by the U.S. FDA 2017-2019
- Premium Statistic Rate of approval for Indian pharma ANDA by U.S. FDA 2017-2019
- Premium Statistic Patented drugs revenue in prescribed drug market in India 2008-2015
- Premium Statistic Lupin's net sales FY 2015-2022
Further related statistics
10
- International tourism receipts of India 2011-2022
- John Lewis sales revenue in the United Kingdom (UK) 2009-2023
- Waitrose sales revenue in the United Kingdom (UK) 2009-2023
- Revenue of the Bank of Communications 2022
- Total revenue at Bertelsmann SE & Co. KGaA, 2003-2023
- Total revenue of Prudential Financial 2006-2022
- Net revenue from investment banking at Goldman Sachs 2009-2023
- Sales of International House of Pancakes (IHOP) restaurants in the U.S. 2009-2023
- Gross revenue of the InterContinental Hotels Group worldwide 2007-2023
- Revenue of Booking Holdings worldwide 2007-2023
Further Content: You might find this interesting as well
Statistics
- International tourism receipts of India 2011-2022
- John Lewis sales revenue in the United Kingdom (UK) 2009-2023
- Waitrose sales revenue in the United Kingdom (UK) 2009-2023
- Revenue of the Bank of Communications 2022
- Total revenue at Bertelsmann SE & Co. KGaA, 2003-2023
- Total revenue of Prudential Financial 2006-2022
- Net revenue from investment banking at Goldman Sachs 2009-2023
- Sales of International House of Pancakes (IHOP) restaurants in the U.S. 2009-2023
- Gross revenue of the InterContinental Hotels Group worldwide 2007-2023
- Revenue of Booking Holdings worldwide 2007-2023
Sun Pharma. (July 27, 2023). Profit after taxes of Sun Pharmaceutical Industries Limited from financial year 2014 to 2023 (in billion Indian rupees) [Graph]. In Statista. Retrieved April 20, 2024, from https://www.statista.com/statistics/990422/india-sun-pharma-profits-after-tax/
Sun Pharma. "Profit after taxes of Sun Pharmaceutical Industries Limited from financial year 2014 to 2023 (in billion Indian rupees)." Chart. July 27, 2023. Statista. Accessed April 20, 2024. https://www.statista.com/statistics/990422/india-sun-pharma-profits-after-tax/
Sun Pharma. (2023). Profit after taxes of Sun Pharmaceutical Industries Limited from financial year 2014 to 2023 (in billion Indian rupees). Statista. Statista Inc.. Accessed: April 20, 2024. https://www.statista.com/statistics/990422/india-sun-pharma-profits-after-tax/
Sun Pharma. "Profit after Taxes of Sun Pharmaceutical Industries Limited from Financial Year 2014 to 2023 (in Billion Indian Rupees)." Statista, Statista Inc., 27 Jul 2023, https://www.statista.com/statistics/990422/india-sun-pharma-profits-after-tax/
Sun Pharma, Profit after taxes of Sun Pharmaceutical Industries Limited from financial year 2014 to 2023 (in billion Indian rupees) Statista, https://www.statista.com/statistics/990422/india-sun-pharma-profits-after-tax/ (last visited April 20, 2024)
Profit after taxes of Sun Pharmaceutical Industries Limited from financial year 2014 to 2023 (in billion Indian rupees) [Graph], Sun Pharma, July 27, 2023. [Online]. Available: https://www.statista.com/statistics/990422/india-sun-pharma-profits-after-tax/